exelixis inc (EXEL:NASDAQ GS)
J. Scott Garland
Chief Commercial Officer and Executive Vice President, Exelixis, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
As of Fiscal Year 2013
Mr. J. Scott Garland has been Executive Vice President and Chief Commercial Officer at Exelixis, Inc. since October 25, 2011. Mr. Garland oversees the commercial functions of marketing, sales and commercial operations, and collaborate closely with Exelixis' development and manufacturing teams to provide commercial perspective for cabozantinib development efforts across multiple oncology indications. Mr. Garland is a seasoned biotechnology and pharmaceutical industry ...
210 East Grand AvenuePhone: 650-837-7000
South San Francisco, California 94080
Board Members Memberships*There is no Board Members Memberships data available.
California State Polytechnic University, Pomona
|Ron Squarer BSc (Biochemistry), MBA||Chief Executive Officer and Director|
Array BioPharma, Inc.
|James A. Bianco M.D.||Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee|
CTI BioPharma Corp.
|Ali Fattaey Ph.D.||Chief Executive Officer, President and Director|
|James M. Gower||Chairman, Chief Executive Officer and Member of Finance Committee|
Rigel Pharmaceuticals, Inc.
|Myung-Joong Cho Ph.D.||Founder, Chief Executive Officer and President|
|--||Compensation as of Fiscal Year 2014.|